Workhorse Group Inc. (WKHS)
NASDAQ: WKHS · Real-Time Price · USD
1.740
+0.090 (5.45%)
At close: Aug 4, 2025, 4:00 PM
1.750
+0.010 (0.57%)
After-hours: Aug 4, 2025, 7:58 PM EDT
CTI BioPharma Stock Forecast
WKHS's stock price has decreased by -89.21% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CTI BioPharma stock has a target of 15.62, which predicts a 797.70% increase from the current stock price of 1.74.
Price Target: $15.62 (+797.70%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 20, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for CTI BioPharma is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $3.12 → $16 | Hold | Maintains | $3.12 → $16 | +797.70% | Nov 20, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $38 → $3.12 | Hold | Maintains | $38 → $3.12 | +79.31% | Aug 21, 2024 |
| DA Davidson | DA Davidson | Hold Maintains $250 → $125 | Hold | Maintains | $250 → $125 | +7,083.91% | Apr 1, 2024 |
| RF Lafferty | RF Lafferty | Hold → Strong Sell Downgrades $75 | Hold → Strong Sell | Downgrades | $75 | +4,210.34% | Mar 13, 2024 |
| RF Lafferty | RF Lafferty | Strong Buy → Hold Downgrades $250 | Strong Buy → Hold | Downgrades | $250 | +14,267.82% | Nov 15, 2023 |
Financial Forecast
Revenue This Year
10.20M
from 6.62M
Increased by 54.16%
Revenue Next Year
18.87M
from 10.20M
Increased by 85.00%
EPS This Year
-15.86
from -51.69
EPS Next Year
-4.34
from -15.86
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 10.5M | 19.4M |
| Avg | 10.2M | 18.9M |
| Low | 9.8M | 18.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 58.7% | 90.4% |
| Avg | 54.2% | 85.0% |
| Low | 48.1% | 77.7% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -16.33 | -4.46 |
| Avg | -15.86 | -4.34 |
| Low | -15.24 | -4.17 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.